These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26616150)

  • 1. Meta-analysis of transforming growth factor β receptor I 6A/9A gene polymorphism and breast cancer risk: the picture remains murky.
    Ou C; Li H; Liu JH; Drummen GP; Zhu B; Huang LS; Huang Y; Li LQ
    Biomarkers; 2015; 20(6-7):487-94. PubMed ID: 26616150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of the association of transforming growth factor β receptor I 6A/9A gene polymorphism with ovarian cancer risk.
    Liu LL; Wei YP; Xu H; Huang Y; Luo FE; Huang ZJ; Mai H; Deng L; Yin Y
    J Recept Signal Transduct Res; 2014 Aug; 34(4):313-6. PubMed ID: 24512448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer.
    Colleran G; McInerney N; Rowan A; Barclay E; Jones AM; Curran C; Miller N; Kerin M; Tomlinson I; Sawyer E
    Breast Cancer Res Treat; 2010 Jan; 119(2):437-42. PubMed ID: 19390964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
    Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
    Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TbetaR-I(6A) is a candidate tumor susceptibility allele.
    Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
    Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.
    Liao RY; Mao C; Qiu LX; Ding H; Chen Q; Pan HF
    Mol Biol Rep; 2010 Oct; 37(7):3227-32. PubMed ID: 19882361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers.
    Jin Q; Hemminki K; Grzybowska E; Klaes R; Söderberg M; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Pamula J; Pekala W; Försti A
    Int J Cancer; 2004 Oct; 112(1):94-9. PubMed ID: 15305380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of polymorphisms on TGFBR1 and colorectal cancer risk: a meta-analysis.
    Zhang X; Wu L; Sheng Y; Zhou W; Huang Z; Qu J; Gao G; Cai D; Zhang M
    Mol Biol Rep; 2012 Mar; 39(3):2567-74. PubMed ID: 21858550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
    Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
    J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need for clarification of data in the recent meta-analysis about TGFBR1*6A/9A polymorphism and breast cancer risk.
    Zhang Y
    Breast Cancer Res Treat; 2011 Dec; 130(3):1073-4. PubMed ID: 21987037
    [No Abstract]   [Full Text] [Related]  

  • 11. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
    Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
    BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between TGFBR1*6A and lung cancer.
    You W; Liu Z; Zhao J; Zheng M; Zheng SY; Liu X; Zhang HT
    J Thorac Oncol; 2007 Jul; 2(7):657-9. PubMed ID: 17607123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
    Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
    Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic acquisition and signaling of TGFBR1*6A in cancer.
    Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
    JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGFBR1 polymorphism and risk of breast cancer in Iranian women.
    Kamali E; Hemmati S; Safari F; Tavassoli M
    Int J Biol Markers; 2015 Nov; 30(4):e414-7. PubMed ID: 26165686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.
    Wang YQ; Qi XW; Wang F; Jiang J; Guo QN
    PLoS One; 2012; 7(8):e42899. PubMed ID: 22905183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.
    Dutt SS; Chen N; Darbary HK; Swede H; Petrelli NJ; Stoler DL; Anderson GR
    Mutat Res; 2008 Oct; 645(1-2):27-32. PubMed ID: 18778720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TbetaR-I(6A) polymorphism is not a tumor susceptibility allele in Macedonian colorectal cancer patients. Correspondence re: B. Pasche et al. Type I TbetaR-I(6A) Is a Candidate Tumor Susceptibility Allele. Cancer Res., 58: 2727-2732, 1998.
    Stefanovska AM; Efremov GD; Dimovski AJ; Jasar D; Zografski G; Josifovski T; Panovski M; Jankova R; Spiroski M
    Cancer Res; 2001 Nov; 61(22):8351-2. PubMed ID: 11719470
    [No Abstract]   [Full Text] [Related]  

  • 20. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract.
    Pasche B; Luo Y; Rao PH; Nimer SD; Dmitrovsky E; Caron P; Luzzatto L; Offit K; Cordon-Cardo C; Renault B; Satagopan JM; Murty VV; Massagué J
    Cancer Res; 1998 Jul; 58(13):2727-32. PubMed ID: 9661882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.